Home > Boards > US Listed > Biotechs >

Amarin Corp. PLC ADS (AMRN)

AMRN RSS Feed
Add AMRN Price Alert      Hide Sticky   Hide Intro
Moderator: ziploc_1, massulo52, zmanindc, golf stud, iryokabu, Number sleven
Search This Board: 
Last Post: 5/20/2022 7:35:44 PM - Followers: 1078 - Board type: Free - Posts Today: 101

AMARIN TICKER RELATED LINKS
Amarin Webpage
NASDAQ AMRN Quote 
Y! Finance AMRN Landing Page 
Seeking Alpha AMRN Landing Page
FinViz AMRN Landing Page


VASCEPA RELATED LINKS & Outside Organizational News
The EPA Drug Initiative (EPADI)
Vascepa Savings Card Program
FDA Orange Book entry for Vascepa
Vascepa Prescribing Information
Vascepa Marine DTC Patient Brochure
Nissui EPA Synthesis History & Methodology
FDA Approval of Vascepa for the Reduction of Triglyceride Levels ≥ 500mg/dL (26 Jul 2012)
Pure EPA Vascepa Now Available in Half-Gram Capsule Size (25 Oct 2016)
ADA’s 2019 Standards of Medical Care in Diabetes Incorporate Findings from REDUCE-IT (28 Mar 2019)
New 2019 Updates to the European Society of Cardiology and European Atherosclerosis Society’s Guidelines incorporate Reduce-IT (3 Sep 2019)
National Lipid Association’s New Position Statement on Use of Icosapent Ethyl (16 Sep 2019)
Independent Drug-Pricing Assessment Finds Vascepa Cost-Effective (17 Oct 2019)

RELEVANT SOCIAL MEDIA ACCOUNTS
Amarin Instagram - @amarincorp Amarin Twitter - @amarincorp Amarin LinkedIn Amarin ADP Portal - Job Openings Dr. Bhatt Twitter - @DLBHATTMD
TerraPharma Twitter - @TerraPharma1 John Cappello Twitter - @JohnCappello RafunRafun Twitter - @ra_fun K Trivedi Twitter - @GPUWorld  
 

VASCEPA CLINICAL TRIALS + FDA Meetings
Marine & Anchor (Amarin Led)
MARINE Study meets primary endpoints(29 Nov 2010)
ANCHOR Trial meets all Primary and Secondary Endpoints (18 Apr 2011)
Additional Inflammatory Marker Data from Marine and Anchor (22 Jan 2013)
New Clinical Data Showing Significant Reductions in Apolipoprotein C-III Levels in Marine and Anchor (8 April 2013)
FDA AD-Com Outcome for Anchor sNDA (16 October 2013)
FDA delays ANCHOR sNDA (20 Dec 2013)
Presentation of MARINE and ANCHOR analyses at AHA showing significant reduction of remnant-like particle cholesterol (17 Nov 2014)
Marine & Anchor Key Summaries (2017)
Vascepa showed reductions in potentially atherogenic lipids and inflammatory markers – Anchor post-hoc (12 Mar 2018)

REDUCE-IT (Amarin Led)
NIH Clinical Trial Page
Amarin Announces Dosing of First Patient in REDUCE-IT (7 Dec 2011)
Amarin and FDA Reaffirm Concurrence on REDUCE-IT through SPA Agreement Amendment (4 Aug 2016)
Amarin Randomizes Final Patient into REDUCE-IT (31 Aug 2016)
REDUCE-IT to Continue As Planned at Recommendation of Independent Data Monitoring Committee (14 Aug 2017)
REDUCE-IT Meets Primary Endpoint (24 Sep 2018)
REDUCE-IT Displayed 25% RRR in 5-Point MACE (10 Nov 2018)
REDUCE-IT NEJM Article(3 Jan 2019)
REDUCE-IT showed 30% reduction in total Cardiovascular events (18 Mar 2019)
Amarin submits sNDA seeking new indication based on REDUCE-IT (28 Mar 2019)
FDA Grants Priority Review for Vascepa sNDA (29 May 2019)
Amarin Notified of Ad-Com Meeting Planned for Nov 2019 (8 Aug 2019)
REDUCE-IT USA-specific Results released (11 Nov 2019)
FDA AD-Com Outcome for REDUCE-IT sNDA (14 Nov 2019)
REDUCE-IT related data presented at 2019 AHA (18 Nov 2019)

Law Suits
Amarin Granted Summary Judgement against FDA seeking NCE market exclusivity (28 May 2015)
First Amendment Decision a win for Amarin & Physician Plaintiffs (7 Aug 2015)
Court Approves Proposed Settlement Terms in Amarin First Amendment Litigation (9 Mar 2016)
Amarin announces patent litigation settlement agreement with TEVA (24 May 2018)
Section Pending

PARTNERSHIPS / OVERSEAS
Amarin and Eddingpharm announce agreement for Vascepa in China (26 Feb 2015)
Amarin and HLS announce agreement for Vascepa in Canada (25 Sep 2017)
Commencement of Vascepa Clinical Development in China (17 Jan 2018)
Biologix and Amarin announce approval of Vascepa in Lebanon for patients with Triglyceride Levels ≥ 500mg/dL (21 Mar 2018)
Amarin & Mochida Announce Collaboration on Future Development of EPA-Based Drug Products and Indications (12 Jun 2018)
Biologix and Amarin announce approval of Vascepa in UAE for patients with Triglyceride Levels ≥ 500mg/dL (26 Jul 2018)
Vascepa granted Priority Review from Health Canada New Drug Submission, anticipated to be filed in April 2019 by HLS (29 Mar 2019)
HLS files New Drug Submission for Vascepa with Health Canada (29 April 2019)

PATENTS
Amarin list of Patents on Justia (h/t @Terrapharma1)

EPA Trials for other indications
Section Pending

Non-Vascepa (AMR-101) Amarin Trials
Section Pending

 

AMRN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMRN News: Current Report Filing (8-k) 03:48 AM
AMRN News: Amarin Announces Appointment of New Directors and Board Leadership Changes 05/19/2022 04:23:13 AM
AMRN News: Research Presented at the American Heart Association’s Quality of Care and Outcomes Research (QCOR) Scientific Sessions Indicate Potential for VASCEPA® (icosapent ethyl) to Reduce Major Adverse Cardiovascular (CV) Events and Associated Costs 05/16/2022 04:00:00 AM
AMRN News: Amarin to Present at Two Upcoming Investor Conferences 05/12/2022 04:00:00 AM
AMRN News: Current Report Filing (8-k) 05/04/2022 03:10:45 AM
News News Alert: Current Report Filing (8-k) 05/20/2022 03:48:47 AM
PostSubject
#378100   Took forever for Fidelity to process my check Rick001 05/20/22 07:35:44 PM
#378099   Re Dow has suffered longest losing streak in Whalatane 05/20/22 07:20:04 PM
#378098   Charles, great link, thanks swg_tdr 05/20/22 07:04:32 PM
#378097   chas123, how come the market and US patent swg_tdr 05/20/22 06:51:34 PM
#378096   Need you and FFS to be committed to FlyFishingStocks 05/20/22 06:39:54 PM
#378095   Thanks Sleven, these legal docs go above my Gusman 05/20/22 04:17:30 PM
#378094   Gusman, I can't read it. According to the Number sleven 05/20/22 04:15:58 PM
#378093   jasbg, I wasn't suggesting that they SHOULD be JRoon71 05/20/22 04:15:38 PM
#378092   Thx for the numbers . Whalatane 05/20/22 04:14:23 PM
#378091   You don't buy 6% of the company and dogn 05/20/22 04:13:31 PM
#378090   Hi Sleven, any idea what this motion means? thanks Gusman 05/20/22 04:10:57 PM
#378089   JRoon, Remember this case were referred to here jasbg 05/20/22 04:08:40 PM
#378088   Re your comment It can be a Whalatane 05/20/22 04:05:52 PM
#378087   yup. short covering into the weekend. FlyFishingStocks 05/20/22 04:03:09 PM
#378086   Kiwi It can be a good buy if iwanderer 05/20/22 04:03:03 PM
#378085   Wait. is the S&P about to turn positive ? Whalatane 05/20/22 04:00:38 PM
#378084   tm100 They should just hire lawyers for the board hayward 05/20/22 03:42:34 PM
#378083   https://www.courtlistener.com/docket/59859757/dr-reddys-laboratories-inc-v-amari Number sleven 05/20/22 03:36:28 PM
#378082   Amarin sued OmegaVia and won. JRoon71 05/20/22 03:33:04 PM
#378081   if the Naz / S&P etc make new FlyFishingStocks 05/20/22 03:22:15 PM
#378080   Ok. By more at $1.37 Not advising Whalatane 05/20/22 03:19:05 PM
#378079   Absolutely. The current draft was written before I chas1232123 05/20/22 03:00:01 PM
#378078   I was just thinking we should do that chas1232123 05/20/22 02:53:52 PM
#378077   With the board changes, wonder if the company tm100 05/20/22 02:50:33 PM
#378076   The smart … in this case “ inside Whalatane 05/20/22 02:44:11 PM
#378075   I would include/add the link to marjac’s petition north40000 05/20/22 02:44:07 PM
#378074   If you have insurance that covers Vascepa and chas1232123 05/20/22 02:39:28 PM
#378073   FFS Agree!! There will be no more BUYING iwanderer 05/20/22 02:33:44 PM
#378072   Did we ever do a lunch, dinner with north40000 05/20/22 02:30:59 PM
#378071   kiwi - It’s not a disaster to me FlyFishingStocks 05/20/22 02:25:07 PM
#378070   Thanks Ziploc - I still have a few chas1232123 05/20/22 02:22:51 PM
#378069   Kiwi it would be a DISATER because it iwanderer 05/20/22 02:22:00 PM
#378068   It’s not a disaster to me It’s a Whalatane 05/20/22 02:06:12 PM
#378067   north- I was being a bit silly even Skipperdog11 05/20/22 02:03:11 PM
#378066   Kiwi + FFS It would be a CATASTROPHIC iwanderer 05/20/22 01:48:21 PM
#378065   Much obliged. I’ll read it. north40000 05/20/22 01:38:13 PM
#378064   FFS. If AMRN goes under $1 , I Whalatane 05/20/22 01:35:48 PM
#378063   Charles, I am glad to see you have ziploc_1 05/20/22 01:34:08 PM
#378062   Does that product cost you less than $36 north40000 05/20/22 01:33:29 PM
#378061   You are not getting that Omega Via prescribed rosemountbomber 05/20/22 01:27:23 PM
#378060   Bio stocks ready to get taken out back FlyFishingStocks 05/20/22 01:24:42 PM
#378059   Link to a downloadable pdf file of my chas1232123 05/20/22 01:18:36 PM
#378058   IBB and IWM have not fallen to new FlyFishingStocks 05/20/22 01:17:54 PM
#378057   GV is obviously infringing in spite of the shadolane 05/20/22 01:02:03 PM
#378056   $AMRN Hello my friends. Today is Friday, April CaptBeer 05/20/22 12:56:57 PM
#378055   Everyone and their second cousin is on watch Whalatane 05/20/22 12:55:56 PM
#378054   OT. In light of todays market' - a jasbg 05/20/22 12:52:14 PM
#378053   "Would it be appropriate for Amarin to amend Skipperdog11 05/20/22 12:49:03 PM
#378052   How about a pdf version for us non-tweeters, non-twitters? north40000 05/20/22 12:45:48 PM
#378051   Zip. I would prefer to wait also. Just biopa 05/20/22 12:42:11 PM
PostSubject
Consent Preferences